Jarro-Dophilus EPS By Jarrow Formulas Overview & Drug Interactions
Check For Interactions With Jarro-Dophilus EPS
Supplement: Jarro-Dophilus EPS by Jarrow Formulas
This product contains
Below is a list of the 'active' ingredients listed on the supplement label for this product.
For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.
Probiotic Bacteria Blend
Ingredient Group | Blend (non-nutrient/non-botanical) |
---|---|
Category | blend |
-
L. rhamnosus
Ingredient Group Lactobacillus rhamnosus Category bacteria
L. helveticus
Ingredient Group Lactobacillus helveticus Category bacteria Forms- L. acidophilus
Pediococcus acidilactici
Ingredient Group Pediococcus acidilactici Category bacteria
L. casei R0215
Ingredient Group Lactobacillus casei Category bacteria
B. longum BB536
Ingredient Group Bifidobacterium longum Category bacteria
L. plantarum
Ingredient Group Lactobacillus plantarum Category bacteria
B. breve
Ingredient Group Bifidobacterium breve Category bacteria
Lactococcus lactis ssp. lactis
Ingredient Group Lactococcus lactis Category bacteria
Drugs that interact with Jarro-Dophilus EPS by Jarrow Formulas
Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.
Label Information
Supplement Facts:
Daily Value (DV) Target Group(s): | Adults and children 4 or more years of age |
---|---|
Minimum serving Sizes: |
1 Capsule(s)
|
Maximum serving Sizes: |
1 Capsule(s)
|
Servings per container | 15 |
UPC/BARCODE | 790011030225 |
Ingredient | Amount per Serving | Group | % DV, Adults & children 4+ years |
---|---|---|---|
Probiotic Bacteria Blend |
5000000000 Viable Cell(s)
|
Blend (non-nutrient/non-botanical) |
--
|
L. rhamnosus |
0 NP
|
Lactobacillus rhamnosus |
|
L. helveticus |
0 NP
|
Lactobacillus helveticus |
|
Pediococcus acidilactici |
0 NP
|
Pediococcus acidilactici |
|
L. casei R0215 |
0 NP
|
Lactobacillus casei |
|
B. longum BB536 |
0 NP
|
Bifidobacterium longum |
|
L. plantarum |
0 NP
|
Lactobacillus plantarum |
|
B. breve |
0 NP
|
Bifidobacterium breve |
|
Lactococcus lactis ssp. lactis |
0 NP
|
Lactococcus lactis |
|
Other Ingredients: |
Potato Starch
Magnesium Stearate
Vitamin C
Vegetarian capsule
Forms
|
---|
Label Statments:
General Statements |
- Supports intestinal & immune function & health*
- Probiotic strains such as B. longum BB536, L. rhamnosus R0011 and L. helveticus R0052 are well characterized and have been shown to have the ability to interact, via multiple mechanisms of action, with the intestinal tract and the microbial ecosystem within it.* These strains have been clinically shown to have a positive influence on the composition of the intestinal microflora, promote intestinal health and support immune response.*
- The Perfect Dophilus for People on the go!
- 8 Strains
- TRAVEL SIZE
- - With Clinically Documented Strains
- Room Temperature Stable
- No Refrigeration Required!
8 Beneficial Probiotic Strains
- Intestinal & Immune Function & Health*
- Individually Blister Sealed
- 5 BILLION PER CAPSULE
|
---|---|
Suggested/Recommended/Usage/Directions |
- USAGE: Take 1 capsule up to 4 times per day with water or juice, preferably on an empty stomach, or as directed by your qualified healthcare professional.
|
Brand IP Statement(s) |
- Jarro-Dophilus EPS(R) is a Stable-Dophilus(R) probiotic due to its shelf life stability at room temperature and its enteric coating delivery system which protects the beneficial probiotic strains while in transit through the stomach’s acidic environment.* The delivery system ensures that a maximum number of viable cells are delivered into the intestinal tract, where they can fully exert their beneficial effects.*
- EnteroGuard(R) ensures the maximum survival of probiotic bacteria to the small intestines, and hence enhances their effectiveness
- Jarrow Formulas(R) puts the “PRO” in probiotics(R)
- (C) 2014 Jarrow FORMULAS(R)
- Enhanced Probiotic System(TM)
- - EnteroGuard(R) Coating
|
Formula |
- The strains in Jarro-Dophilus EPS(R) are selected from the following 4 genera: Lactobacillus, Bifidobacterium, Lactococcus and Pediococcus.
- Contains: Dairy (milk) and soy (in trace amounts).
- 5 Billion viable cells per capsule at time of consumption, under recommended storage conditions and within Best Used Before Date.
|
Storage |
- Storage Instructions: Jarro-Dophilus EPS(R) is room temperature stable and does not require refrigeration. Refrigeration will, however, extend the shelf-life. Avoid temperatures above 77(0)F (25(0)C).
|
Precautions |
- Keep out of the reach of children.
- Contains: Dairy (milk) and soy (in trace amounts).
|
Seals/Symbols |
- GLUTEN FREE
- NON GENETICALLY MODIFIED NON GMO
- v vegetarian
- LALLEMAND TECHNOLOGY star
- {Happy Intestines}(TM)
|
FDA Disclaimer Statement |
- *These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
|
General |
- 01414JEP15 PROD # 103022
|
Formulation |
- Vegetarian
- No wheat, no gluten, no egg, no fish/shellfish, no peanuts/tree nuts.
|
FDA Statement of Identity |
- PROBIOTIC SUPPLEMENT
|
Brand Information
See all products by this brand
for | |
---|---|
Name | Jarrow Formulas Superior Nutrition and Formulation |
Street Address | P.O. Box 35994 |
City | Los Angeles |
State | CA |
ZipCode | 90035-4317 |
Web Address | www.Jarrow.com |
Made in Canada by | |
Name | Lallemand Health Solutions, Inc. |
Return to the main supplement interaction checker page
Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC
Drug descriptions are provided by MedlinePlus.